XBiotech
XBIT
XBIT
56 hedge funds and large institutions have $18.9M invested in XBiotech in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less capital invested
Capital invested by funds: $34.7M → $18.9M (-$15.8M)
70% less call options, than puts
Call options by funds: $7K | Put options by funds: $23K
Holders
56
Holding in Top 10
–
Calls
$7K
Puts
$23K
Top Buyers
| 1 | +$1.51M | |
| 2 | +$929K | |
| 3 | +$772K | |
| 4 |
Renaissance Technologies
New York
|
+$443K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$396K |
Top Sellers
| 1 | -$4.36M | |
| 2 | -$1.5M | |
| 3 | -$818K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$764K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$763K |